Trial intelligence / Profile preview

5% vs 10% Povidone-Iodine for Intravitreal Injection Antisepsis

NCT03420820Unknown

Start
Mar 2018
Primary completion
Apr 2018
01

Overview

Randomised, single-blind trial of povidone-iodine in endophthalmitis and ocular infection (3 arms). Primary endpoint: Colony-Forming Units at 3 months. Status: unknown.

02

Drugs

povidone-iodine
03

Conditions

endophthalmitisocular infection

Beyond the preview

Go deeper on NCT03420820.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03420820.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call